2,850 results on '"Thyssen, Jacob P"'
Search Results
202. 351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis
203. Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials
204. Access to psoriasis treatment in Brazil and Chile: A cross-sectional multi-centre `Global Healthcare Study on Psoriasis
205. Adverse reactions after oral provocation with aluminium in children with vaccination granulomas and aluminium contact allergy
206. Prevalence, incidence and relative risk of cardiovascular disease risk factors in adults with atopic dermatitis: A systematic review
207. Short‐term real‐world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis
208. Long-term disease control in atopic dermatitis using biologics
209. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies
210. Prevalence and risk factors for atopic dermatitis in Greenlandic children
211. The European baseline series and recommended additions: 2023
212. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
213. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis
214. Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis
215. Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity
216. Artificial Nails and Long-lasting Nail Polish in Danish Hairdressers: Self-use, Occupational Exposure and Related Eczema
217. Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial
218. The association between atopic dermatitis, cognitive function and school performance in children and young adults
219. Update on Comorbidities in Psoriasis
220. Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma
221. Nationwide Assessment of Cause-Specific Mortality in Patients with Rosacea: A Cohort Study in Denmark
222. Chromium and Allergic Reponses
223. Acute and Recurrent Vesicular Hand Dermatitis
224. Filaggrin Gene Defects and Dry Skin Barrier Function
225. 651 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.
226. Prevalence of ichthyoses in Denmark: a nationwide registry-based study.
227. Clinical characteristics of combined rosacea and migraine
228. Comorbidities of atopic dermatitis-what does the evidence say?
229. Contact allergy to metals in metalworkers: A systematic review and meta‐analysis
230. Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin
231. Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level
232. Prevalence and incidence of hand eczema in healthcare workers: protocol for a systematic review and meta-analysis
233. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis
234. The road to biologics in patients with hidradenitis suppurativa: a nationwide drug utilization study
235. Delay in diagnosis and treatment of patients with psoriasis: a population-based cross-sectional study
236. A nationwide skin protection program introduced in hairdressing vocational schools was followed by a decreased risk of occupational hand eczema
237. Skin biomarkers predict development of atopic dermatitis in infancy
238. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
239. 33233 Long-term efficacy (to 68 weeks) of baricitinib in adult patients with moderate to severe atopic dermatitis (AD) who were treatment responders or partial responders and originally included in the combination topical corticosteroids study BREEZE-AD7
240. Biological therapy for young children with atopic dermatitis
241. 34358 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis (AD): Results from an open-label extension (OLE) trial up to 4 years
242. 32496 Efficacy and safety of abrocitinib according to geographies
243. 34599 Achieving incrementally greater skin improvement thresholds with upadacitinib versus dupilumab in moderate-to-severe atopic dermatitis (AD): Heads Up study results
244. Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?
245. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
246. Contributions of human tissue analysis to understanding the mechanisms of loosening and osteolysis in total hip replacement
247. Paradoxical psoriasis after dupilumab treatment of prurigo nodularis treated with adalimumab
248. 52267 Effectiveness and safety of oral roflumilast in patients with hidradenitis suppurativa: A prospective single-center study
249. 51843 Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa: results from the 700 first patients of the Copenhagen Hidradenitis Suppurativa Cohort Study
250. 51561 The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with disease severity, asthma and rhinitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.